Navigation Links
Avisena Announces Major Increases in Profit for Second Quarter 2009
Date:8/18/2009

Revenue Cycle Management Specialists, Avisena, Announces Increased Earnings for the Second Quarter, Including Positive Operating Profit for the Year-to-Date.

Miami, FL (PRWEB) August 18, 2009 -- Avisena, Inc., a revenue cycle management (RCM) company servicing the health care industry that offers a proprietary, Internet-based technology platform, announced strong second quarter results driven by a growing demand in healthcare practice management solutions. Avisena cites consistent sales productivity, technology enhancements as well as operational improvements as the reason for the companies continued financial success.

Operating profit was up 148 percent compared to the same quarter in 2008. Avisena continues to thrive in the midst of a struggling US (Global) economy and is well on track to deliver an eighth consecutive year of steady financial growth.

"Even in these economically difficult times, Avisena is continually hiring and creating opportunities in the communities we do business; we also are increasing shareholder value by steady growth and projected increases in revenue," said Mike Maseda, Avisena President and CEO. "Avisena has experienced a 20 percent growth in year-to-date claims revenue from '08 to '09. These metrics can be attributed to our continued innovation, relentless focus on client service, and superior client collection results," explained Maseda.

According to the Medical Group Management Association 73 percent of practices are dealing with operating costs that are rising more rapidly than revenue. Traditionally run medical practices are being squeezed by increasing cost pressure coupled with declining payer reimbursement resulting in significant reduction in profits. In order to combat these on-going trends, practices are turning to Avisena's Software Enabled Service (SES) model for more efficient and cost effective solutions to reduce expenses and increase revenues.

"Physicians are asking how they can save money and do more with decreasing revenue," said Maseda. "Avisena is uniquely positioned to help our customers save money by offering advanced technologies that will help physicians streamline the payer reimbursement process. It is commonplace for Avisena clients to experience 10% to 20% revenue growth while simultaneously reducing their expenses to their bottom-line."

In addition to notable increase in profits, Q2 presented Avisena with national recognition for its economic consistency and growth in recent years. Accolades include ranking as the 1,018 fastest-growing company in Inc 500/5000 2009 list as well as local recognition as the Greater Miami Chamber of Commerce's "Good to Great Business in the 51-249 employee category" and the South Florida Business Journal "Business of the Year."

About Avisena:
Avisena is a revenue cycle management company that helps medical practices improve collections through the use of its Internet-based medical billing software technology and practice management expertise. By streamlining front and back office processes, Avisena helps medical practices Collect More, Spend Less and Live Better. Visit Avisena online at http://www.avisena.com.

# # #

Read the full story at http://www.prweb.com/releases/revenuecyclemanagement/avisena/prweb2748704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase
2. Accelify Announces Training Dates for Missouri Medicaid Consortium
3. Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024
4. Gaiam Announces New Deal With Valerie Bertinelli
5. MHA Announces Gloria Barr, Esq. as Vice President & General Counsel
6. LifeCare Holdings, Inc. Announces Second Quarter Results
7. Secretary Shinseki Announces Expansion of Counseling for Combat Veterans
8. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter Fiscal 2010 Financial Results
9. Purple Communications(TM) Announces Second Quarter 2009 Results
10. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
11. Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... presents its enhanced Pepper Flow promotional review platform at the Promotional Review ... increased insight-driven capabilities help marketers streamline the medical, legal, and regulatory review ...
Breaking Medicine News(10 mins):
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)...  Consumer reviews on the independent review site Consumer Affairs ... company for hearing aids, ranking it higher than Miracle Ear ... ... For Hearing Aids ... online store that provides high performance, state-of-the-art, German-engineered hearing aids directly ...
Breaking Medicine Technology: